Increased production of inflammatory cytokines by circulating monocytes in mesial temporal lobe epilepsy : A possible role in drug resistance
Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved..
We analyzed peripheral blood mononuclear cells (PBMCs) and serum inflammatory biomarkers in patients with mesial temporal lobe epilepsy (drug-resistant - DR, vs. drug-sensitive - DS). Patients with epilepsy showed higher levels of serum CCL2, CCL3, IL-8 and AOPP, and lower levels of FRAP and thiols compared to healthy controls (HC). Although none of the serum biomarkers distinguished DR from DS patients, when analysing intracellular cytokines after in vitro stimulation, DR patients presented higher percentages of IL-1β and IL-6 positive monocytes compared to DS patients and HC. Circulating innate immune cells might be implicated in DR epilepsy and constitute potential new targets for treatments.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:386 |
|---|---|
| Enthalten in: |
Journal of neuroimmunology - 386(2024) vom: 15. Jan., Seite 578272 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Milano, C [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Biomarkers |
|---|
| Anmerkungen: |
Date Completed 15.01.2024 Date Revised 18.01.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jneuroim.2023.578272 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM366507613 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM366507613 | ||
| 003 | DE-627 | ||
| 005 | 20240118232052.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240108s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jneuroim.2023.578272 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1263.xml |
| 035 | |a (DE-627)NLM366507613 | ||
| 035 | |a (NLM)38160122 | ||
| 035 | |a (PII)S0165-5728(23)00258-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Milano, C |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Increased production of inflammatory cytokines by circulating monocytes in mesial temporal lobe epilepsy |b A possible role in drug resistance |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 15.01.2024 | ||
| 500 | |a Date Revised 18.01.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved. | ||
| 520 | |a We analyzed peripheral blood mononuclear cells (PBMCs) and serum inflammatory biomarkers in patients with mesial temporal lobe epilepsy (drug-resistant - DR, vs. drug-sensitive - DS). Patients with epilepsy showed higher levels of serum CCL2, CCL3, IL-8 and AOPP, and lower levels of FRAP and thiols compared to healthy controls (HC). Although none of the serum biomarkers distinguished DR from DS patients, when analysing intracellular cytokines after in vitro stimulation, DR patients presented higher percentages of IL-1β and IL-6 positive monocytes compared to DS patients and HC. Circulating innate immune cells might be implicated in DR epilepsy and constitute potential new targets for treatments | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Cytokines | |
| 650 | 4 | |a Drug-resistant epilepsy | |
| 650 | 4 | |a Mesial temporal lobe epilepsy | |
| 650 | 4 | |a Neuroinflammation | |
| 650 | 4 | |a Oxidative stress | |
| 650 | 4 | |a Peripheral blood mononuclear cells | |
| 650 | 7 | |a Cytokines |2 NLM | |
| 650 | 7 | |a Biomarkers |2 NLM | |
| 700 | 1 | |a Montali, M |e verfasserin |4 aut | |
| 700 | 1 | |a Barachini, S |e verfasserin |4 aut | |
| 700 | 1 | |a Burzi, I S |e verfasserin |4 aut | |
| 700 | 1 | |a Pratesi, F |e verfasserin |4 aut | |
| 700 | 1 | |a Petrozzi, L |e verfasserin |4 aut | |
| 700 | 1 | |a Chico, L |e verfasserin |4 aut | |
| 700 | 1 | |a Morganti, R |e verfasserin |4 aut | |
| 700 | 1 | |a Gambino, G |e verfasserin |4 aut | |
| 700 | 1 | |a Rossi, L |e verfasserin |4 aut | |
| 700 | 1 | |a Ceravolo, R |e verfasserin |4 aut | |
| 700 | 1 | |a Siciliano, G |e verfasserin |4 aut | |
| 700 | 1 | |a Migliorini, P |e verfasserin |4 aut | |
| 700 | 1 | |a Petrini, I |e verfasserin |4 aut | |
| 700 | 1 | |a Pizzanelli, C |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of neuroimmunology |d 1985 |g 386(2024) vom: 15. Jan., Seite 578272 |w (DE-627)NLM012614181 |x 1872-8421 |7 nnns |
| 773 | 1 | 8 | |g volume:386 |g year:2024 |g day:15 |g month:01 |g pages:578272 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jneuroim.2023.578272 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 386 |j 2024 |b 15 |c 01 |h 578272 | ||